LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Education
• Science
• Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

article, bortezomib, google, scholar, pubmed, myeloma, cas, multiple, pharmaceuticals, cancer, patients, proteasome, millennium, usa, relapsed, phase, research, dose, richardson, johnson, study, blood, trial, data, inhibitor, haematol, renumeration, privacy, cookies, content, doses, reece, repeat, treatment, dosing, inhibition, clin, oncol, information, publish, search, chemotherapy, pharmacokinetic, lonial, iii, administration, day, group, results, systemic,

Topics {✒️}

month download article/chapter melphalan-prednisone versus melphalan-prednisone front velcade-thalidomide-dexamethasone compared androgen-independent prostate cancer 2018 population-based meta-analysis article cancer chemotherapy advanced solid tumors bortezomib/dexamethasone versus vad howard burris iii pharmacokinetics/pharmacodynamics bortezomib exposure–response relationships full article pdf richardson pg proteasome inhibition measurements advanced multiple myeloma privacy choices/manage cookies related subjects princess margaret hospital michael karol & lisa maximum inhibition ranging multiple myeloma treated ubiquitin-proteasome pathway proteasome inhibitor velcade relapsed multiple myeloma proteasome inhibitor bortezomib refractory multiple myeloma cytochrome p450 reaction repeat intravenous administration early clinical evaluation evaluating disease response synta pharmaceuticals corp front-line treatment von moltke milin acharya peter zannikos terminal half-life readily apparent deviation suitable antineoplastic target reactive oxygen species fact/gog-ntx acknowledge editorial assistance consultancy/advisory role proteasome inhibition high-dose therapy conditions privacy policy michael karol european economic area narrow dose range high-dose dexamethasone pharmacodynamic end points

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma
         description:Characterize bortezomib pharmacokinetics/pharmacodynamics in relapsed myeloma patients after single and repeat intravenous administration at two doses. Forty-two patients were randomized to receive bortezomib 1.0 or 1.3 mg/m2, days 1, 4, 8, 11, for up to eight 21-day treatment cycles (n = 21, each dose group). Serial blood samples for pharmacokinetic/pharmacodynamic analysis were taken on days 1 and 11, cycles 1 and 3. Observational efficacy and safety data were collected. Twelve patients in each dose group were evaluable for pharmacokinetics/pharmacodynamics. Plasma clearance decreased with repeat dosing (102–112 L/h for first dose; 15–32 L/h following repeat dosing), with associated increases in systemic exposure and terminal half-life. Systemic exposures of bortezomib were similar between dose groups considering the relatively narrow dose range and the observed pharmacokinetic variability, although there was no readily apparent deviation from dose-proportionality. Blood 20S proteasome inhibition profiles were similar between groups with mean maximum inhibition ranging from 70 to 84% and decreasing toward baseline over the dosing interval. Response rate (all 42 patients) was 50%, including 7% complete responses. The safety profile was consistent with the predictable and manageable profile previously established; data suggested milder toxicity in the 1.0 mg/m2 group. Bortezomib pharmacokinetics change with repeat dose administration, characterized by a reduction in plasma clearance and associated increase in systemic exposure. Bortezomib is pharmacodynamically active and tolerable at 1.0 and 1.3 mg/m2 doses, with recovery toward baseline blood proteasome activity over the dosing interval following repeat dose administration, supporting the current clinical dosing regimen.
         datePublished:2010-03-20T00:00:00Z
         dateModified:2010-03-20T00:00:00Z
         pageStart:57
         pageEnd:67
         sameAs:https://doi.org/10.1007/s00280-010-1283-3
         keywords:
            Pharmacodynamics
            Pharmacokinetics
            Bortezomib
            Multiple myeloma
            Proteasome inhibition
            Oncology
            Pharmacology/Toxicology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-010-1283-3/MediaObjects/280_2010_1283_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-010-1283-3/MediaObjects/280_2010_1283_Fig2_HTML.gif
         isPartOf:
            name:Cancer Chemotherapy and Pharmacology
            issn:
               1432-0843
               0344-5704
            volumeNumber:67
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Donna E. Reece
               affiliation:
                     name:Princess Margaret Hospital
                     address:
                        name:Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Dan Sullivan
               affiliation:
                     name:H. Lee Moffitt Cancer Center
                     address:
                        name:H. Lee Moffitt Cancer Center, Tampa, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sagar Lonial
               affiliation:
                     name:Emory University Hospital
                     address:
                        name:Emory University Hospital, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ann F. Mohrbacher
               affiliation:
                     name:University of Southern California
                     address:
                        name:University of Southern California, Los Angeles, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gurkamal Chatta
               affiliation:
                     name:University of Pittsburgh Cancer Institute
                     address:
                        name:University of Pittsburgh Cancer Institute, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chaim Shustik
               affiliation:
                     name:Royal Victoria Hospital
                     address:
                        name:Royal Victoria Hospital, Montreal, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Howard Burris
               affiliation:
                     name:The Sarah Cannon Cancer Center
                     address:
                        name:The Sarah Cannon Cancer Center, Nashville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Karthik Venkatakrishnan
               affiliation:
                     name:Millennium Pharmaceuticals Inc
                     address:
                        name:Millennium Pharmaceuticals Inc, Cambridge, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rachel Neuwirth
               affiliation:
                     name:Millennium Pharmaceuticals Inc
                     address:
                        name:Millennium Pharmaceuticals Inc, Cambridge, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:William J. Riordan
               affiliation:
                     name:Millennium Pharmaceuticals Inc
                     address:
                        name:Millennium Pharmaceuticals Inc, Cambridge, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michael Karol
               affiliation:
                     name:Millennium Pharmaceuticals Inc
                     address:
                        name:Millennium Pharmaceuticals Inc, Cambridge, USA
                        type:PostalAddress
                     type:Organization
                     name:Synta Pharmaceuticals Corp
                     address:
                        name:Synta Pharmaceuticals Corp, Lexington, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lisa L. von Moltke
               affiliation:
                     name:Millennium Pharmaceuticals Inc
                     address:
                        name:Millennium Pharmaceuticals Inc, Cambridge, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Milin Acharya
               affiliation:
                     name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C
                     address:
                        name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C, Raritan, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peter Zannikos
               affiliation:
                     name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C
                     address:
                        name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C, Raritan, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A. Keith Stewart
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Mayo Clinic, Scottsdale, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma
      description:Characterize bortezomib pharmacokinetics/pharmacodynamics in relapsed myeloma patients after single and repeat intravenous administration at two doses. Forty-two patients were randomized to receive bortezomib 1.0 or 1.3 mg/m2, days 1, 4, 8, 11, for up to eight 21-day treatment cycles (n = 21, each dose group). Serial blood samples for pharmacokinetic/pharmacodynamic analysis were taken on days 1 and 11, cycles 1 and 3. Observational efficacy and safety data were collected. Twelve patients in each dose group were evaluable for pharmacokinetics/pharmacodynamics. Plasma clearance decreased with repeat dosing (102–112 L/h for first dose; 15–32 L/h following repeat dosing), with associated increases in systemic exposure and terminal half-life. Systemic exposures of bortezomib were similar between dose groups considering the relatively narrow dose range and the observed pharmacokinetic variability, although there was no readily apparent deviation from dose-proportionality. Blood 20S proteasome inhibition profiles were similar between groups with mean maximum inhibition ranging from 70 to 84% and decreasing toward baseline over the dosing interval. Response rate (all 42 patients) was 50%, including 7% complete responses. The safety profile was consistent with the predictable and manageable profile previously established; data suggested milder toxicity in the 1.0 mg/m2 group. Bortezomib pharmacokinetics change with repeat dose administration, characterized by a reduction in plasma clearance and associated increase in systemic exposure. Bortezomib is pharmacodynamically active and tolerable at 1.0 and 1.3 mg/m2 doses, with recovery toward baseline blood proteasome activity over the dosing interval following repeat dose administration, supporting the current clinical dosing regimen.
      datePublished:2010-03-20T00:00:00Z
      dateModified:2010-03-20T00:00:00Z
      pageStart:57
      pageEnd:67
      sameAs:https://doi.org/10.1007/s00280-010-1283-3
      keywords:
         Pharmacodynamics
         Pharmacokinetics
         Bortezomib
         Multiple myeloma
         Proteasome inhibition
         Oncology
         Pharmacology/Toxicology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-010-1283-3/MediaObjects/280_2010_1283_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-010-1283-3/MediaObjects/280_2010_1283_Fig2_HTML.gif
      isPartOf:
         name:Cancer Chemotherapy and Pharmacology
         issn:
            1432-0843
            0344-5704
         volumeNumber:67
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Donna E. Reece
            affiliation:
                  name:Princess Margaret Hospital
                  address:
                     name:Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Dan Sullivan
            affiliation:
                  name:H. Lee Moffitt Cancer Center
                  address:
                     name:H. Lee Moffitt Cancer Center, Tampa, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sagar Lonial
            affiliation:
                  name:Emory University Hospital
                  address:
                     name:Emory University Hospital, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ann F. Mohrbacher
            affiliation:
                  name:University of Southern California
                  address:
                     name:University of Southern California, Los Angeles, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gurkamal Chatta
            affiliation:
                  name:University of Pittsburgh Cancer Institute
                  address:
                     name:University of Pittsburgh Cancer Institute, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chaim Shustik
            affiliation:
                  name:Royal Victoria Hospital
                  address:
                     name:Royal Victoria Hospital, Montreal, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Howard Burris
            affiliation:
                  name:The Sarah Cannon Cancer Center
                  address:
                     name:The Sarah Cannon Cancer Center, Nashville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Karthik Venkatakrishnan
            affiliation:
                  name:Millennium Pharmaceuticals Inc
                  address:
                     name:Millennium Pharmaceuticals Inc, Cambridge, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rachel Neuwirth
            affiliation:
                  name:Millennium Pharmaceuticals Inc
                  address:
                     name:Millennium Pharmaceuticals Inc, Cambridge, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:William J. Riordan
            affiliation:
                  name:Millennium Pharmaceuticals Inc
                  address:
                     name:Millennium Pharmaceuticals Inc, Cambridge, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michael Karol
            affiliation:
                  name:Millennium Pharmaceuticals Inc
                  address:
                     name:Millennium Pharmaceuticals Inc, Cambridge, USA
                     type:PostalAddress
                  type:Organization
                  name:Synta Pharmaceuticals Corp
                  address:
                     name:Synta Pharmaceuticals Corp, Lexington, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lisa L. von Moltke
            affiliation:
                  name:Millennium Pharmaceuticals Inc
                  address:
                     name:Millennium Pharmaceuticals Inc, Cambridge, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Milin Acharya
            affiliation:
                  name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C
                  address:
                     name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C, Raritan, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peter Zannikos
            affiliation:
                  name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C
                  address:
                     name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C, Raritan, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A. Keith Stewart
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Mayo Clinic, Scottsdale, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Chemotherapy and Pharmacology
      issn:
         1432-0843
         0344-5704
      volumeNumber:67
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Princess Margaret Hospital
      address:
         name:Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada
         type:PostalAddress
      name:H. Lee Moffitt Cancer Center
      address:
         name:H. Lee Moffitt Cancer Center, Tampa, USA
         type:PostalAddress
      name:Emory University Hospital
      address:
         name:Emory University Hospital, Atlanta, USA
         type:PostalAddress
      name:University of Southern California
      address:
         name:University of Southern California, Los Angeles, USA
         type:PostalAddress
      name:University of Pittsburgh Cancer Institute
      address:
         name:University of Pittsburgh Cancer Institute, Pittsburgh, USA
         type:PostalAddress
      name:Royal Victoria Hospital
      address:
         name:Royal Victoria Hospital, Montreal, Canada
         type:PostalAddress
      name:The Sarah Cannon Cancer Center
      address:
         name:The Sarah Cannon Cancer Center, Nashville, USA
         type:PostalAddress
      name:Millennium Pharmaceuticals Inc
      address:
         name:Millennium Pharmaceuticals Inc, Cambridge, USA
         type:PostalAddress
      name:Millennium Pharmaceuticals Inc
      address:
         name:Millennium Pharmaceuticals Inc, Cambridge, USA
         type:PostalAddress
      name:Millennium Pharmaceuticals Inc
      address:
         name:Millennium Pharmaceuticals Inc, Cambridge, USA
         type:PostalAddress
      name:Millennium Pharmaceuticals Inc
      address:
         name:Millennium Pharmaceuticals Inc, Cambridge, USA
         type:PostalAddress
      name:Synta Pharmaceuticals Corp
      address:
         name:Synta Pharmaceuticals Corp, Lexington, USA
         type:PostalAddress
      name:Millennium Pharmaceuticals Inc
      address:
         name:Millennium Pharmaceuticals Inc, Cambridge, USA
         type:PostalAddress
      name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C
      address:
         name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C, Raritan, USA
         type:PostalAddress
      name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C
      address:
         name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C, Raritan, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Mayo Clinic, Scottsdale, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Donna E. Reece
      affiliation:
            name:Princess Margaret Hospital
            address:
               name:Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Dan Sullivan
      affiliation:
            name:H. Lee Moffitt Cancer Center
            address:
               name:H. Lee Moffitt Cancer Center, Tampa, USA
               type:PostalAddress
            type:Organization
      name:Sagar Lonial
      affiliation:
            name:Emory University Hospital
            address:
               name:Emory University Hospital, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:Ann F. Mohrbacher
      affiliation:
            name:University of Southern California
            address:
               name:University of Southern California, Los Angeles, USA
               type:PostalAddress
            type:Organization
      name:Gurkamal Chatta
      affiliation:
            name:University of Pittsburgh Cancer Institute
            address:
               name:University of Pittsburgh Cancer Institute, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:Chaim Shustik
      affiliation:
            name:Royal Victoria Hospital
            address:
               name:Royal Victoria Hospital, Montreal, Canada
               type:PostalAddress
            type:Organization
      name:Howard Burris
      affiliation:
            name:The Sarah Cannon Cancer Center
            address:
               name:The Sarah Cannon Cancer Center, Nashville, USA
               type:PostalAddress
            type:Organization
      name:Karthik Venkatakrishnan
      affiliation:
            name:Millennium Pharmaceuticals Inc
            address:
               name:Millennium Pharmaceuticals Inc, Cambridge, USA
               type:PostalAddress
            type:Organization
      name:Rachel Neuwirth
      affiliation:
            name:Millennium Pharmaceuticals Inc
            address:
               name:Millennium Pharmaceuticals Inc, Cambridge, USA
               type:PostalAddress
            type:Organization
      name:William J. Riordan
      affiliation:
            name:Millennium Pharmaceuticals Inc
            address:
               name:Millennium Pharmaceuticals Inc, Cambridge, USA
               type:PostalAddress
            type:Organization
      name:Michael Karol
      affiliation:
            name:Millennium Pharmaceuticals Inc
            address:
               name:Millennium Pharmaceuticals Inc, Cambridge, USA
               type:PostalAddress
            type:Organization
            name:Synta Pharmaceuticals Corp
            address:
               name:Synta Pharmaceuticals Corp, Lexington, USA
               type:PostalAddress
            type:Organization
      name:Lisa L. von Moltke
      affiliation:
            name:Millennium Pharmaceuticals Inc
            address:
               name:Millennium Pharmaceuticals Inc, Cambridge, USA
               type:PostalAddress
            type:Organization
      name:Milin Acharya
      affiliation:
            name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C
            address:
               name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C, Raritan, USA
               type:PostalAddress
            type:Organization
      name:Peter Zannikos
      affiliation:
            name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C
            address:
               name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C, Raritan, USA
               type:PostalAddress
            type:Organization
      name:A. Keith Stewart
      affiliation:
            name:Mayo Clinic
            address:
               name:Mayo Clinic, Scottsdale, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Canada
      name:H. Lee Moffitt Cancer Center, Tampa, USA
      name:Emory University Hospital, Atlanta, USA
      name:University of Southern California, Los Angeles, USA
      name:University of Pittsburgh Cancer Institute, Pittsburgh, USA
      name:Royal Victoria Hospital, Montreal, Canada
      name:The Sarah Cannon Cancer Center, Nashville, USA
      name:Millennium Pharmaceuticals Inc, Cambridge, USA
      name:Millennium Pharmaceuticals Inc, Cambridge, USA
      name:Millennium Pharmaceuticals Inc, Cambridge, USA
      name:Millennium Pharmaceuticals Inc, Cambridge, USA
      name:Synta Pharmaceuticals Corp, Lexington, USA
      name:Millennium Pharmaceuticals Inc, Cambridge, USA
      name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C, Raritan, USA
      name:Johnson & Johnson Pharmaceutical Research & Development, L.L.C, Raritan, USA
      name:Mayo Clinic, Scottsdale, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(132)

• https://www.springernature.com/gp/authors's financial summary
• How much income does https://link.springernature.com/home/ have?
• https://order.springer.com/public/cart's total income per month
• What's the financial outcome of https://submission.springernature.com/new-submission/280/3?
• Discover the revenue of https://www.springernature.com/gp/librarians/licensing/agc/journals
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=VELCADE%C2%AE%20%28bortezomib%29&publication_year=2009&author=Janssen-Cilag%20International%2CNV?
• Check the income stats for https://doi.org/10.1073%2Fpnas.95.6.2727
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9501156's gross income?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=The%20ubiquitin-proteasome%20pathway%3A%20the%20complexity%20and%20myriad%20functions%20of%20proteins%20death&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.95.6.2727&volume=95&pages=2727-2730&publication_year=1998&author=Ciechanover%2CA&author=Schwartz%2CAL
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15929791 pull in?
• Find out how much http://scholar.google.com/scholar_lookup?&title=Preclinical%20evaluation%20of%20the%20proteasome%20inhibitor%20bortezomib%20in%20cancer%20therapy&journal=Cancer%20Cell%20Int&doi=10.1186%2F1475-2867-5-18&volume=5&publication_year=2005&author=Boccadoro%2CM&author=Morgan%2CG&author=Cavenagh%2CJ earns monthly
• How much does https://doi.org/10.1038%2Fnrc1361 earn?
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15122206's gross income?
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=The%20proteasome%3A%20a%20suitable%20antineoplastic%20target&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc1361&volume=4&pages=349-360&publication_year=2004&author=Adams%2CJ?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Superior%20complete%20response%20rate%20and%20progression-free%20survival%20after%20autologous%20transplantation%20with%20up-front%20Velcade-thalidomide-dexamethasone%20compared%20with%20thalidomide-dexamethasone%20in%20newly%20diagnosed%20multiple%20myeloma&journal=Blood&volume=112&publication_year=2008&author=Cavo%2CM&author=Tacchetti%2CP&author=Patriarca%2CF?
• How much does https://doi.org/10.1200%2FJCO.2007.13.2415 bring in each month?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Bortezomib%2Fdexamethasone%20versus%20VAD%20as%20induction%20prior%20to%20autologous%20stem%20cell%20transplantion%20%28ASCT%29%20in%20previously%20untreated%20multiple%20myeloma%20%28MM%29%3A%20Updated%20data%20from%20IFM%202005%2F01%20trial&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2007.13.2415&volume=26&publication_year=2008&author=Harousseau%2CJL&author=Mathiot%2CC&author=Attal%2CM
• What's the financial intake of https://doi.org/10.1586%2F14737140.8.7.1053?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18588451 pull in?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Bortezomib%20in%20the%20front-line%20treatment%20of%20multiple%20myeloma&journal=Expert%20Rev%20Anticancer%20Ther&doi=10.1586%2F14737140.8.7.1053&volume=8&pages=1053-1072&publication_year=2008&author=Richardson%2CPG&author=Mitsiades%2CC&author=Schlossman%2CR
• What are the total earnings of https://doi.org/10.1056%2FNEJMoa0801479?
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18753647
• Profit of http://scholar.google.com/scholar_lookup?&title=Bortezomib%20plus%20melphalan%20and%20prednisone%20for%20initial%20treatment%20of%20multiple%20myeloma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa0801479&volume=359&pages=906-917&publication_year=2008&author=San%20Miguel%2CJF&author=Schlag%2CR&author=Khuageva%2CNK
• Profit of https://doi.org/10.1111%2Fj.1365-2141.2004.05188.x
• What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15461622?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=A%20phase%202%20study%20of%20two%20doses%20of%20bortezomib%20in%20relapsed%20or%20refractory%20myeloma&journal=Br%20J%20Haematol&doi=10.1111%2Fj.1365-2141.2004.05188.x&volume=127&pages=165-172&publication_year=2004&author=Jagannath%2CS&author=Barlogie%2CB&author=Berenson%2CJ?
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18783399
• How much profit is http://scholar.google.com/scholar_lookup?&title=Updated%20survival%20analyses%20after%20prolonged%20follow-up%20of%20the%20phase%202%2C%20multicenter%20CREST%20study%20of%20bortezomib%20in%20relapsed%20or%20refractory%20multiple%20myeloma&journal=Br%20J%20Haematol&volume=143&pages=537-540&publication_year=2008&author=Jagannath%2CS&author=Barlogie%2CB&author=Berenson%2CJR making per month?
• https://doi.org/10.1056%2FNEJMoa030288's financial summary
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12826635 income
• http://scholar.google.com/scholar_lookup?&title=A%20phase%202%20study%20of%20bortezomib%20in%20relapsed%2C%20refractory%20myeloma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa030288&volume=348&pages=2609-2617&publication_year=2003&author=Richardson%2CPG&author=Barlogie%2CB&author=Berenson%2CJ's financial summary
• How much does https://doi.org/10.1056%2FNEJMoa043445 pull in monthly?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15958804?
• How much does http://scholar.google.com/scholar_lookup?&title=Bortezomib%20or%20high-dose%20dexamethasone%20for%20relapsed%20multiple%20myeloma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa043445&volume=352&pages=2487-2498&publication_year=2005&author=Richardson%2CPG&author=Sonneveld%2CP&author=Schuster%2CMW make?
• Check the income stats for https://doi.org/10.1097%2F01.cco.0000245320.34658.bd
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16988581 make?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Beyond%20single-agent%20bortezomib%3A%20combination%20regimens%20in%20relapsed%20multiple%20myeloma&journal=Curr%20Opin%20Oncol&doi=10.1097%2F01.cco.0000245320.34658.bd&volume=18&pages=598-608&publication_year=2006&author=Richardson%2CPG&author=Mitsiades%2CC&author=Ghobrial%2CI&author=Anderson%2CK is on a monthly basis
• Financial intake of https://doi.org/10.1182%2Fblood-2006-08-036947
• What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17690257?
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=Extended%20follow-up%20of%20a%20phase%203%20trial%20in%20relapsed%20multiple%20myeloma%3A%20final%20time-to-event%20results%20of%20the%20APEX%20trial&journal=Blood&doi=10.1182%2Fblood-2006-08-036947&volume=110&pages=3557-3560&publication_year=2007&author=Richardson%2CPG&author=Sonneveld%2CP&author=Schuster%2CM?
• See how much http://scholar.google.com/scholar_lookup?&title=Updated%20follow-up%20and%20results%20of%20subsequent%20therapy%20in%20the%20phase%20III%20VISTA%20trial%3A%20bortezomib%20plus%20melphalan-prednisone%20versus%20melphalan-prednisone%20in%20newly%20diagnosed%20multiple%20myeloma&journal=Blood&volume=112&publication_year=2008&author=San%20Miguel%2CJF&author=Schlag%2CR&author=Khuageva%2CNK makes per month
• Get to know what's the income of https://doi.org/10.1081%2FCNV-120030218
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15199612 bring in?
• How much does http://scholar.google.com/scholar_lookup?&title=Development%20of%20the%20proteasome%20inhibitor%20Velcade%20%28Bortezomib%29&journal=Cancer%20Invest&doi=10.1081%2FCNV-120030218&volume=22&pages=304-311&publication_year=2004&author=Adams%2CJ&author=Kauffman%2CM pull in?
• What's the monthly income of https://doi.org/10.1200%2FJCO.2004.02.106?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15169797 make?
• http://scholar.google.com/scholar_lookup?&title=Phase%20I%20trial%20of%20the%20proteasome%20inhibitor%20bortezomib%20in%20patients%20with%20advanced%20solid%20tumors%20with%20observations%20in%20androgen-independent%20prostate%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2004.02.106&volume=22&pages=2108-2121&publication_year=2004&author=Papandreou%2CCN&author=Daliani%2CDD&author=Nix%2CD's total income per month
• What's the revenue for https://doi.org/10.1021%2Ftx050313d?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16608165?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Oxidative%20deboronation%20of%20the%20peptide%20boronic%20acid%20proteasome%20inhibitor%20bortezomib%3A%20contributions%20from%20reactive%20oxygen%20species%20in%20this%20novel%20cytochrome%20P450%20reaction&journal=Chem%20Res%20Toxicol&doi=10.1021%2Ftx050313d&volume=19&pages=539-546&publication_year=2006&author=Labutti%2CJ&author=Parsons%2CI&author=Huang%2CR&author=Miwa%2CG&author=Gan%2CLS&author=Daniels%2CJS generate?
• Check the income stats for https://doi.org/10.1124%2Fdmd.104.002956
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15764713?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Human%20metabolism%20of%20the%20proteasome%20inhibitor%20bortezomib%3A%20identification%20of%20circulating%20metabolites&journal=Drug%20Metab%20Dispos&doi=10.1124%2Fdmd.104.002956&volume=33&pages=771-777&publication_year=2005&author=Pekol%2CT&author=Daniels%2CJS&author=Labutti%2CJ produce monthly?
• Revenue of https://doi.org/10.1124%2Fdmd.105.005710
• What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16103134?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Relative%20contributions%20of%20the%20five%20major%20human%20cytochromes%20P450%2C%201A2%2C%202C9%2C%202C19%2C%202D6%2C%20and%203A4%2C%20to%20the%20hepatic%20metabolism%20of%20the%20proteasome%20inhibitor%20bortezomib&journal=Drug%20Metab%20Dispos&doi=10.1124%2Fdmd.105.005710&volume=33&pages=1723-1728&publication_year=2005&author=Uttamsingh%2CV&author=Lu%2CC&author=Miwa%2CG&author=Gan%2CLS have monthly?
• How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10794750 have monthly?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Proteasome%20inhibition%20measurements%3A%20clinical%20application&journal=Clin%20Chem&volume=46&pages=673-683&publication_year=2000&author=Lightcap%2CES&author=McCormack%2CTA&author=Pien%2CCS&author=Chau%2CV&author=Adams%2CJ&author=Elliott%2CPJ is on a monthly basis
• https://doi.org/10.1046%2Fj.1365-2141.1998.00930.x income
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9753033 generate?
• Revenue of http://scholar.google.com/scholar_lookup?&title=Criteria%20for%20evaluating%20disease%20response%20and%20progression%20in%20patients%20with%20multiple%20myeloma%20treated%20by%20high-dose%20therapy%20and%20haemopoietic%20stem%20cell%20transplantation.%20Myeloma%20subcommittee%20of%20the%20EBMT.%20European%20group%20for%20blood%20and%20marrow%20transplant&journal=Br%20J%20Haematol&doi=10.1046%2Fj.1365-2141.1998.00930.x&volume=102&pages=1115-1123&publication_year=1998&author=Blad%C3%A9%2CJ&author=Samson%2CD&author=Reece%2CD
• How much does https://doi.org/10.1111%2Fj.1525-1438.2003.13603.x generate monthly?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14675309's financial summary
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Psychometric%20evaluation%20of%20the%20functional%20assessment%20of%20cancer%20therapy%2Fgynecologic%20oncology%20group-neurotoxicity%20%28Fact%2FGOG-Ntx%29%20questionnaire%20for%20patients%20receiving%20systemic%20chemotherapy&journal=Int%20J%20Gynecol%20Cancer&doi=10.1111%2Fj.1525-1438.2003.13603.x&volume=13&pages=741-748&publication_year=2003&author=Calhoun%2CEA&author=Welshman%2CEE&author=Chang%2CCH?
• How much revenue does https://doi.org/10.3324%2Fhaematol.13285 generate?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18768528's revenue stream
• How much income does http://scholar.google.com/scholar_lookup?&title=Prospective%20comparison%20of%20subcutaneous%20versus%20intravenous%20administration%20of%20bortezomib%20in%20patients%20with%20multiple%20myeloma&journal=Haematologica&doi=10.3324%2Fhaematol.13285&volume=93&pages=1908-1911&publication_year=2008&author=Moreau%2CP&author=Coiteux%2CV&author=Hulin%2CC have?
• How profitable is https://doi.org/10.1200%2FJCO.2005.01.136?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16135477 make?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Proteasome%20inhibition%20with%20bortezomib%20%28PS-341%29%3A%20a%20phase%20I%20study%20with%20pharmacodynamic%20end%20points%20using%20a%20day%201%20and%20day%204%20schedule%20in%20a%2014-day%20cycle&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.01.136&volume=23&pages=6107-6116&publication_year=2005&author=Hamilton%2CAL&author=Eder%2CJP&author=Pavlick%2CAC
• How much does https://doi.org/10.1111%2Fj.1365-2141.2008.06997.x gross monthly?
• What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18371113?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Bortezomib%2C%20doxorubicin%20and%20dexamethasone%20%28PAD%29%20front-line%20treatment%20of%20multiple%20myeloma%3A%20updated%20results%20after%20long-term%20follow-up&journal=Br%20J%20Haematol&doi=10.1111%2Fj.1365-2141.2008.06997.x&volume=141&pages=512-516&publication_year=2008&author=Popat%2CR&author=Oakervee%2CHE&author=Hallam%2CS
• How profitable is https://doi.org/10.1111%2Fj.1365-2141.2008.07321.x?
• What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18713253?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Characterisation%20of%20haematological%20profiles%20and%20low%20risk%20of%20thromboembolic%20events%20with%20bortezomib%20in%20patients%20with%20relapsed%20multiple%20myeloma&journal=Br%20J%20Haematol&doi=10.1111%2Fj.1365-2141.2008.07321.x&volume=143&pages=222-229&publication_year=2008&author=Lonial%2CS&author=Richardson%2CPG&author=San%2CMJ make?
• https://doi.org/10.1200%2FJCO.2005.04.7779's revenue stream
• How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16754936 have?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Frequency%2C%20characteristics%2C%20and%20reversibility%20of%20peripheral%20neuropathy%20during%20treatment%20of%20advanced%20multiple%20myeloma%20with%20bortezomib&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.04.7779&volume=24&pages=3113-3120&publication_year=2006&author=Richardson%2CPG&author=Briemberg%2CH&author=Jagannath%2CS?
• How much income is https://doi.org/10.1111%2Fj.1365-2141.2008.07573.x earning monthly?
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19170677
• What's the income of http://scholar.google.com/scholar_lookup?&title=Reversibility%20of%20symptomatic%20peripheral%20neuropathy%20with%20bortezomib%20in%20the%20phase%20III%20APEX%20trial%20in%20relapsed%20multiple%20myeloma%3A%20impact%20of%20a%20dose-modification%20guideline&journal=Br%20J%20Haematol&doi=10.1111%2Fj.1365-2141.2008.07573.x&volume=144&pages=895-903&publication_year=2009&author=Richardson%2CPG&author=Sonneveld%2CP&author=Schuster%2CMW?
• How much income does https://citation-needed.springer.com/v2/references/10.1007/s00280-010-1283-3?format=refman&flavour=references have?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Donna%20E.%20Reece earn?
• Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Donna%20E.%20Reece%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dan%20Sullivan pull in monthly?
• How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dan%20Sullivan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sagar%20Lonial
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sagar%20Lonial%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
• Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ann%20F.%20Mohrbacher
• What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ann%20F.%20Mohrbacher%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Gurkamal%20Chatta bring in?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Gurkamal%20Chatta%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
• Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Chaim%20Shustik
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Chaim%20Shustik%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Howard%20Burris's total income per month
• Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Howard%20Burris%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Karthik%20Venkatakrishnan?
• How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Karthik%20Venkatakrishnan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
• What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Rachel%20Neuwirth?
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Rachel%20Neuwirth%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=William%20J.%20Riordan produce monthly?
• Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22William%20J.%20Riordan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michael%20Karol net monthly?
• Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michael%20Karol%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lisa%20L.%20von%20Moltke
• What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lisa%20L.%20von%20Moltke%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Milin%20Acharya
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Milin%20Acharya%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Peter%20Zannikos's total income per month
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Peter%20Zannikos%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A.%20Keith%20Stewart's revenue stream
• What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A.%20Keith%20Stewart%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Get to know https://static-content.springer.com/esm/art%3A10.1007%2Fs00280-010-1283-3/MediaObjects/280_2010_1283_MOESM1_ESM.tif's earnings
• How much does https://s100.copyright.com/AppDispatchServlet?title=Pharmacokinetic%20and%20pharmacodynamic%20study%20of%20two%20doses%20of%20bortezomib%20in%20patients%20with%20relapsed%20multiple%20myeloma&author=Donna%20E.%20Reece%20et%20al&contentID=10.1007%2Fs00280-010-1283-3©right=Springer-Verlag&publication=0344-5704&publicationDate=2010-03-20&publisherName=SpringerNature&orderBeanReset=true pull in?
• Find out how much https://citation-needed.springer.com/v2/references/10.1007/s00280-010-1283-3?format=refman&flavour=citation earns monthly
• Profit of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
• How much does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research gross monthly?
• How much money does https://www.springernature.com/gp/products generate?
• How much does https://www.springernature.com/gp/librarians rake in every month?
• What's the total monthly financial gain of https://www.springernature.com/gp/societies?
• How profitable is https://www.springernature.com/gp/partners?
• Explore the financials of https://www.springer.com/
• What's the revenue for https://www.nature.com/?
• https://www.biomedcentral.com/'s financial summary
• What are the total earnings of https://www.palgrave.com/?
• What's the monthly money flow for https://www.apress.com/?
• Monthly income for https://www.springernature.com/gp/legal/ccpa
• What is the monthly revenue of https://www.springernature.com/gp/info/accessibility?
• What's the financial outcome of https://support.springernature.com/en/support/home?
• Financial intake of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
• https://www.springernature.com/ income

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref